HomeCOHANCE • NSE
add
Cohance Lifesciences Limited
Previous close
₹1,063.70
Day range
₹1,044.00 - ₹1,069.80
Year range
₹990.00 - ₹1,119.00
Market cap
402.84B INR
Avg Volume
207.35K
P/E ratio
100.77
Dividend yield
-
Primary exchange
NSE
Market news
Financials
Income Statement
Revenue
Net income
| (INR) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | 4.02B | 58.94% |
Operating expense | 2.21B | 232.35% |
Net income | 420.10M | -21.29% |
Net profit margin | 10.45 | -50.47% |
Earnings per share | — | — |
EBITDA | 661.52M | -11.29% |
Effective tax rate | 24.94% | — |
Balance Sheet
Total assets
Total liabilities
| (INR) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 2.80B | -65.85% |
Total assets | 30.32B | 34.50% |
Total liabilities | 11.91B | 485.53% |
Total equity | 18.41B | — |
Shares outstanding | 254.61M | — |
Price to book | 15.96 | — |
Return on assets | — | — |
Return on capital | 5.59% | — |
Cash Flow
Net change in cash
| (INR) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | 420.10M | -21.29% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Founded
1989
Website
Employees
1,052
